Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F15%3A00063581" target="_blank" >RIV/00159816:_____/15:00063581 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1161/STROKEAHA.115.010420" target="_blank" >http://dx.doi.org/10.1161/STROKEAHA.115.010420</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1161/STROKEAHA.115.010420" target="_blank" >10.1161/STROKEAHA.115.010420</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event

Popis výsledku v původním jazyce

Background and Purpose-According to the European license, alteplase can be given no sooner than 3 months after previous stroke. However, it is not known whether past history of stroke influences the effect of treatment. Our aim was to evaluate safety andfunctional outcome after intravenous thrombolysis administered in everyday practice to patients with previous stroke LESS-THAN OR EQUAL TO3 months compared with those with first-ever stroke. Methods-We analyzed consecutive cases treated with alteplase between October 2003 and July 2014 contributed to the Safe Implementation of Thrombolysis for Stroke-Eastern Europe registry from 12 countries. Odds ratios were calculated using unadjusted and adjusted logistic regression. Results-Of 13 007 patients, 11 221 (86%) had no history of stroke and 249 (2%) experienced previous stroke LESS-THAN OR EQUAL TO3 months before admission. Patients with previous stroke LESS-THAN OR EQUAL TO3 months had a higher proportion of hypertension and hyperlipide

Název v anglickém jazyce

Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event

Popis výsledku anglicky

Background and Purpose-According to the European license, alteplase can be given no sooner than 3 months after previous stroke. However, it is not known whether past history of stroke influences the effect of treatment. Our aim was to evaluate safety andfunctional outcome after intravenous thrombolysis administered in everyday practice to patients with previous stroke LESS-THAN OR EQUAL TO3 months compared with those with first-ever stroke. Methods-We analyzed consecutive cases treated with alteplase between October 2003 and July 2014 contributed to the Safe Implementation of Thrombolysis for Stroke-Eastern Europe registry from 12 countries. Odds ratios were calculated using unadjusted and adjusted logistic regression. Results-Of 13 007 patients, 11 221 (86%) had no history of stroke and 249 (2%) experienced previous stroke LESS-THAN OR EQUAL TO3 months before admission. Patients with previous stroke LESS-THAN OR EQUAL TO3 months had a higher proportion of hypertension and hyperlipide

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FH - Neurologie, neurochirurgie, neurovědy

OECD FORD obor

—

Projekt

<a href="/cs/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: Fakultní nemocnice u sv. Anny v Brně - Mezinárodní centrum klinického výzkumu (FNUSA - ICRC)</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Stroke

ISSN

0039-2499

e-ISSN

—

Svazek periodika

46

Číslo periodika v rámci svazku

11

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

6

Strana od-do

3184-3189

Kód UT WoS článku

000363974500024

EID výsledku v databázi Scopus

—